DK0531401T3 - Forøgelse af associationen af exogene peptider med MHC klasse I molekyler til immunsystemets celler. - Google Patents

Forøgelse af associationen af exogene peptider med MHC klasse I molekyler til immunsystemets celler.

Info

Publication number
DK0531401T3
DK0531401T3 DK91910429.9T DK91910429T DK0531401T3 DK 0531401 T3 DK0531401 T3 DK 0531401T3 DK 91910429 T DK91910429 T DK 91910429T DK 0531401 T3 DK0531401 T3 DK 0531401T3
Authority
DK
Denmark
Prior art keywords
antigen
microglobulin
class
polypeptides
association
Prior art date
Application number
DK91910429.9T
Other languages
English (en)
Inventor
Kenneth L Rock
Original Assignee
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dana Farber Cancer Inst Inc filed Critical Dana Farber Cancer Inst Inc
Application granted granted Critical
Publication of DK0531401T3 publication Critical patent/DK0531401T3/da

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14—Ultrafiltration; Microfiltration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774—Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/605—MHC molecules or ligands thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Water Supply & Treatment (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Focusing (AREA)
  • Automatic Focus Adjustment (AREA)
  • Studio Devices (AREA)
DK91910429.9T 1990-05-10 1991-05-03 Forøgelse af associationen af exogene peptider med MHC klasse I molekyler til immunsystemets celler. DK0531401T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52157690A 1990-05-10 1990-05-10

Publications (1)

Publication Number Publication Date
DK0531401T3 true DK0531401T3 (da) 1997-07-28

Family

ID=24077258

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91910429.9T DK0531401T3 (da) 1990-05-10 1991-05-03 Forøgelse af associationen af exogene peptider med MHC klasse I molekyler til immunsystemets celler.

Country Status (8)

Country Link
EP (1) EP0531401B1 (da)
JP (1) JPH05506447A (da)
AT (1) ATE147990T1 (da)
AU (1) AU660278B2 (da)
DE (1) DE69124372T2 (da)
DK (1) DK0531401T3 (da)
ES (1) ES2096650T3 (da)
WO (1) WO1991016924A1 (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5336758A (en) * 1990-03-09 1994-08-09 The United States Of America As Represented By The Department Of Health And Human Services Peptides stimulating cytotoxic T cells immune to HIV RT
US5314813A (en) * 1992-02-19 1994-05-24 Scripps Research Institute Drosophila cell lines expressing genes encoding MHC class I antigens and B2-microglobulin and capable of assembling empty complexes and methods of making said cell lines
GB9214871D0 (en) * 1992-07-13 1992-08-26 Medical Res Council Vaccines
DE69418699T2 (de) * 1993-01-11 1999-09-30 Dana-Farber Cancer Institute, Boston Induktion der antworten zytotoxischer t-lymphozyten
GB9307371D0 (en) * 1993-04-08 1993-06-02 Walls Alan J Fusion proteins
EP0796280B1 (en) * 1994-12-28 2003-03-26 University Of Kentucky Murine monoclonal anti-idiotype antibody 3h1
US6949244B1 (en) 1995-12-20 2005-09-27 The Board Of Trustees Of The University Of Kentucky Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof
US20020041872A1 (en) 1996-04-12 2002-04-11 Malaya Chatterjee Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1
US6235280B1 (en) 1996-04-12 2001-05-22 Malaya Chatterjee Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1
US6468782B1 (en) 1996-12-05 2002-10-22 Quadrant Healthcare (Uk) Limited Methods of preserving prokaryotic cells and compositions obtained thereby
US6274143B1 (en) 1997-06-13 2001-08-14 Malaya Chatterjee Methods of delaying development of HMFG-associated tumors using anti-idiotype antibody 11D10
US6355244B1 (en) 1997-11-17 2002-03-12 University Of Kentucky Research Foundation Methods and compositions for the treatment of psoriasis
US6682741B1 (en) 1998-06-10 2004-01-27 The United States Of America As Represented By The Department Of Health And Human Services β2 microglobulin fusion proteins and high affinity variants
US7026155B2 (en) 1999-02-02 2006-04-11 Regents Of The University Of California Method of reducing bacterial proliferation
EP2374470A1 (fr) 2010-04-08 2011-10-12 Beta Innov Utilisation thérapeutique de la protéine Beta2m

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2860875D1 (en) * 1977-09-28 1981-10-15 Nat Res Dev Immunological preparations incorporating mhc antigens and their production
WO1980001986A1 (en) * 1979-03-27 1980-10-02 A Sanderson Improvements in or relating to immunological preparations

Also Published As

Publication number Publication date
EP0531401B1 (en) 1997-01-22
EP0531401A4 (en) 1993-07-14
AU7987391A (en) 1991-11-27
WO1991016924A1 (en) 1991-11-14
EP0531401A1 (en) 1993-03-17
DE69124372D1 (de) 1997-03-06
JPH05506447A (ja) 1993-09-22
ATE147990T1 (de) 1997-02-15
AU660278B2 (en) 1995-06-22
ES2096650T3 (es) 1997-03-16
DE69124372T2 (de) 1997-08-07

Similar Documents

Publication Publication Date Title
EP0531401A4 (en) Enhancing the association of exogenous peptides with class i mhc molecules on immune system cells
Weltzien et al. T cell immune responses to haptens. Structural models for allergic and autoimmune reactions
Katz et al. Immunological focusing by the mouse major histocompatibility complex: mouse strains confronted with distantly related lysozymes confine their attention to very few epitopes
ATE180407T1 (de) Induktion der antworten zytotoxischer t- lymphozyten
BR9406652A (pt) Composição
Sedgwick et al. Isolation of encephalitogenic CD4+ T cell clones in the rat: Cloning methodology and interferon-γ secretion
ATE432085T1 (de) Stimulationsfaktor für dendriten
BR9306820A (pt) Conjugado de um antígeno fracamente imunogênico e um veículo peptideo sintetico vacina processos para melhorar a imunogenicidade de uma molecula de antigeno fracamente imunogenico e para imunizar um hospedeiro mamífero
GR3015791T3 (en) Synthetic peptides useful as universal carriers for the preparation of immunogenic conjugates and their use in the development of synthetic vaccines.
HU9500571D0 (en) Retro-, inverso-, and retro-inverso synthetic peptide analogues
ATE87935T1 (de) Kunstpolypeptide zum nachweis mykobakterieller infektionen.
Tomazic et al. Autoimmune murine thyroiditis. VIII. Role of different thyroid antigens in the induction of experimental autoimmune thyroiditis
DK0570489T3 (da) Leverstadium-specifikke peptidsekvenser af P.falciparum, der bærer epitoper, som er i stand til at stimulere T-lymfocytter
NO963344L (no) Peptider gjenkjent ved melanoma-spesifikke cytotoksiske lymfocytter og anvendelse derav
ATE126237T1 (de) Lymphocyteninhibierung durch hla-peptide.
Guimezanes et al. A viral peptide can mimic an endogenous peptide for allorecognition of a major histocompatibility complex class I product
Curman et al. Presence of alloreactive Ia antigens on murine intestine epithelial cells
Schick et al. The lysis of cytotoxic T lymphocytes and their blasts by cytotoxic T lymphocytes
Linna et al. Inhibition of cytolytic T lymphocyte activity with subcellular alloantigen preparations and with unlabeled allogeneic target cells
Schroer et al. Function of macrophages as antigen presenting cells
NZ532271A (en) Peptide mimics of conserved gonococcal epitopes and methods and compositions using them
KR920002631A (ko) 면역학적 캐리어 및 강화 특성을 지닌 나이세리아 메닌자이티디스 외막의 클래스 ⅱ 단백질
Yoshioka et al. T-cell recognition and antigen presentation of myoglobin. Protein recognition by site-specific T-cell clones is influenced by amino acid substitutions outside the site
O’Brien-Simpson et al. Polymerisation of a T Cell Epitope with an Immunostimulatory C3d Peptide Sequence Enhances Antigen Specific T Cell Responses
Rubin et al. Induction of anti-hapten antibody responses against haptens conjugated to autologous and heterologous proteins